GSK3B and non-small cell lung carcinoma: First, the overexpression of GSK3β in NSCLC tissues was observed when comparing NSCLC tissues with adjacent normal tissues, and this aberrant accumulation of GSK3β in NSCLC cells was associated with a shorter survival time and identified as a novel risk factor for poor prognosis.